Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Merck
McKinsey
Boehringer Ingelheim
Dow

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

LOPERAMIDE HYDROCHLORIDE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Loperamide Hydrochloride patents expire, and what generic alternatives are available?

Loperamide Hydrochloride is a drug marketed by Bionpharma Inc, Mylan, Roxane, Teva, Yaopharma Co Ltd, Allied, Alpharma Us Pharms, Duramed Pharms Barr, Hi Tech Pharma, Perrigo, Watson Labs, Wockhardt Bio Ag, Perrigo R And D, Able, Aurobindo Pharma Ltd, Contract Pharmacal, L Perrigo Co, LNK, Ohm Labs, and Sun Pharm Inds Ltd. and is included in twenty-five NDAs.

The generic ingredient in LOPERAMIDE HYDROCHLORIDE is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.

Drug patent expirations by year for LOPERAMIDE HYDROCHLORIDE
Recent Clinical Trials for LOPERAMIDE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PPDPhase 2
OrphoMed, Inc.Phase 2
National Cancer Institute (NCI)Phase 1

See all LOPERAMIDE HYDROCHLORIDE clinical trials

Pharmacology for LOPERAMIDE HYDROCHLORIDE
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists
Medical Subject Heading (MeSH) Categories for LOPERAMIDE HYDROCHLORIDE
Synonyms for LOPERAMIDE HYDROCHLORIDE
1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-, hydrochloride
1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-, monohydrochloride
1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-,hydrochloride
34552-83-5
4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride
4-(4-(p-Chlorophenyl)-4-hydroxy-1-piperidyl)-N,N-dimethyl-2,2-diphenylbutyramide HCl
4-(4-chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidin-1-ium chloride
4-(4-chlorophenyl)-4-hydroxy- N,N-dimethyl-alpha,alpha-diphenyl- 1-piperidine butanamide
4-(4-Chlorophenyl)-4-hydroxy-N,.alpha.-diphenyl-1-piperidinebutanamide monohydrochloride
4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-?,?-diphenyl-1-piperidinebutanamide hydrochloride
4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidine butanamide
4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenylpiperidine-1-butyramide monohydrochloride
4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidine butyramide HCl
4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidinebutyramide hydrochloride
4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidinebutyramide monohydrochloride
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide hydrochloride
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-n,n-dimethyl-2,2-diphenylbutanamide;hydrochloride
4-[4-(4-chlorophenyl)-4-oxidanyl-piperidin-1-yl]-N,N-dimethyl-2,2-diphenyl-butanamide hydrochloride
53179-11-6 (Parent)
552L835
77TI35393C
A822272
AB0013105
AB2000588
AC-8242
AC1L2G4W
AC1Q3BBG
AKOS015846351
AN-8179
Anti-diarrheal
ARONIS27197
AS-13181
B1392
BC205117
BCP28441
BLOX
BREK
C29H33ClN2O2.HCl
C29H34Cl2N2O2
CCG-39494
CHEBI:6533
CHEMBL1707
CPD000058466
CS-2522
D00729
Diamode
Diar-Aid
Dissenten
EBD2202345
EINECS 252-082-4
EU-0100708
Fortasec
FT-0627973
H536
HMS1568M10
HMS1922J18
HY-B0418A
I06-0646
Imodium
Imodium (TN)
Imodium A-D
Imodium A-D EZ chews
Imosec
Imotil
K-7865
K-Pek II
Kao-Paverin
Kaopectate 1-D
KS-00000GHZ
KS-000048OI
L 4762
L0154
Lopemid
Lopemin
Loperamide Hydrochloride ,(S)
Loperamide (hydrochloride)
Loperamide HCl
Loperamide hydrochloride (JAN/USP)
Loperamide hydrochloride [USAN:JAN]
Loperamide hydrochloride [USAN:USP:JAN]
Loperamide Hydrochloride Capsules
Loperamide hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard
Loperamide hydrochloride, British Pharmacopoeia (BP) Reference Standard
Loperamide hydrochloride, European Pharmacopoeia (EP) Reference Standard
Loperamide hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Loperamide hydrochloride, United States Pharmacopeia (USP) Reference Standard
Loperamide hydrochloride, VETRANAL(TM), analytical standard
Loperamide, HCl
Loperyl
Loseramin
LP00708
LS-114353
Maalox Antidiarrheal
MCULE-8938403173
MFCD00058581
MLS000069779
MLS001148627
MLS002222200
MolPort-003-666-775
NC00572
NCGC00094059-01
NCGC00094059-02
NCGC00094059-03
NCGC00094059-04
NCGC00094059-05
NCGC00180886-01
NCGC00180886-02
NCGC00261393-01
NSC-696356
NSC-759568
NSC696356
NSC759568
Opera_ID_1508
Pepto Diarrhea Control
PGYPOBZJRVSMDS-UHFFFAOYSA-N
Pharmakon1600-02300241
PJ185
Prestwick_302
R 18,553
R 18553
REGID_for_CID_71420
s2480
SAM002564218
SCHEMBL15048
SMR000058466
SPECTRUM2300241
SR-01000075507
SR-01000075507-1
SR-01000075507-3
SR-01000075507-8
Suprasec
SW196602-3
Tebloc
TL8002575
Tox21_500708
UNII-77TI35393C
Up and up anti diarrheal
W-106729

US Patents and Regulatory Information for LOPERAMIDE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 021855-001 Aug 4, 2005 OTC Yes No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 206548-001 Dec 15, 2015 OTC No No   Start Trial   Start Trial   Start Trial
Perrigo LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET, CHEWABLE;ORAL 076029-001 Aug 30, 2002 OTC No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
McKinsey
Boehringer Ingelheim
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.